Pancreatic cancer stage 3. Chemo the 1st June 2015 to the 7th September 2015. In total 7 treatments. His cancer is ductal adenocarcinoma and T3. Commenced GcMAF at the end of September 2015 at a dose of 0.25ml 3 times per week. Scan from 7th December 2015 has revealed a 50% reduction in tumour sizeRead More
Global Medical Discovery has identified your recent peer-reviewed publication: Oleic Acid, Deglycosylated Vitamin D-Binding Protein, Nitric Oxide: A Molecular Triad Made Lethal to Cancer as a Key Scientific Article contributing to excellence in biomedical research. We would therefore like to feature it in our next edition of Global Medical Discovery Series. Global Medical Discovery featuresRead More
American Journal of Immunology 10 (1): 23-32, 2014 The first paper on the results in the GcMAF Treatment Centre has been published. The highlights of the results section include an average tumour reduction of 25% a week, and before and after ultrasonography scans of tumour shrinkage with measurements. Patient 3 is the most representative withRead More
The article in “Nutrients” describing the product that we now call “Goleic”, and that already is in the top 5% of all articles ever tracked by the bibliometric index “Altmetric”, has been selected as a Key Scientific Article contributing to excellence in biomedical research. Therefore, it will be featured it in the next edition ofRead More
